BCM
PETS icon

Bridgeway Capital Management’s PetMed Express PETS Stock Holding History

Bridgeway Capital Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
121,048
-11,676
-9% -$24.8K ﹤0.01% 1025
2026
Q1 		$303K Buy
132,724
+6,373
+5% +$18.5K 0.01% 932
2025
Q4 		$404K Buy
126,351
+18,535
+17% +$46.5K 0.01% 865
2025
Q3 		$271K Buy
107,816
+67,016
+164% +$207K 0.01% 952
2025
Q2 		$135K Buy
40,800
+20,000
+96% +$71.2K ﹤0.01% 1028
2025
Q1 		$87.2K Sell
20,800
-18,200
-47% -$82.7K ﹤0.01% 1062
2024
Q4 		$188K Hold
39,000
– – ﹤0.01% 1026
2024
Q3 		$144K Buy
39,000
+19,000
+95% +$67.3K ﹤0.01% 1117
2024
Q2 		$81K Sell
20,000
-10,500
-34% -$44.8K ﹤0.01% 1181
2024
Q1 		$146K Buy
+30,500
New +$177K ﹤0.01% 1159
2021
Q2 		– Sell
-8,300
Closed -$292K – 1382
2021
Q1 		$292K Buy
+8,300
New +$289K 0.01% 1229
2016
Q1 		– Sell
-18,600
Closed -$319K – 1471
2015
Q4 		$319K Sell
18,600
-1,247
-6% -$21K 0.01% 1190
2015
Q3 		$320K Hold
19,847
– – 0.01% 1195
2015
Q2 		$343K Sell
19,847
-27,000
-58% -$453K 0.01% 1208
2015
Q1 		$774K Buy
46,847
+200
+0.4% +$3.1K 0.02% 903
2014
Q4 		$670K Hold
46,647
– – 0.02% 931
2014
Q3 		$634K Hold
46,647
– – 0.02% 967
2014
Q2 		$629K Hold
46,647
– – 0.02% 980
2014
Q1 		$626K Hold
46,647
– – 0.02% 976
2013
Q4 		$776K Sell
46,647
-63,200
-58% -$987K 0.02% 849
2013
Q3 		$1.79M Hold
109,847
– – 0.06% 474
2013
Q2 		$1.38M Buy
+109,847
New +$1.43M 0.06% 494

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPH
Steel Partners Holdings New York $78M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bridgeway Capital Management's PETS Position: Q2 2026 in Review

Bridgeway Capital Management reduced its PetMed Express (PETS) stake by 8.8% in Q2 2026, selling an estimated $24.8K and leaving 121,048 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Bridgeway Capital Management first reported a position in PETS in Q2 2013 and has held it in 22 quarters since. The position peaked at $1.79M in Q3 2013. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

  • Bridgeway Capital Management held 121,048 shares of PetMed Express worth $232K as of Q2 2026.
  • Bridgeway Capital Management sold 11,676 PetMed Express shares in Q2 2026, an estimated $24.8K.
  • PetMed Express made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1025 holding.
  • Bridgeway Capital Management first reported a position in PetMed Express in Q2 2013 and has held it in 22 quarters since.
  • Bridgeway Capital Management's PetMed Express position peaked at $1.79M in Q3 2013.
  • 50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.